Risk factors for metachronous bilateral renal cell carcinoma: A Surveillance, Epidemiology, and End Results analysis

Patients treated for renal cell carcinoma (RCC) may be diagnosed with a metachronous, contralateral tumor. We evaluated the risks of contralateral tumor development using the Surveillance, Epidemiology, and End Results database.

[1]  B. Shuch,et al.  The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors. , 2012, The Urologic clinics of North America.

[2]  W. Lowrance,et al.  Trends in renal tumor surgery delivery within the United States , 2010, Cancer.

[3]  W. Lowrance,et al.  Developments in the surgical management of sporadic synchronous bilateral renal tumours , 2010, BJU international.

[4]  H. Adami,et al.  Risk of bilateral renal cell cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  L. Schwartz,et al.  Kidney Cancer. , 2009, Cancer journal.

[6]  S. Boorjian,et al.  The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. , 2008, European urology.

[7]  Z. Kırkalı,et al.  Open Partial Nephrectomy in the Management of Small Renal Masses , 2008, Advances in urology.

[8]  K. Sapalidis,et al.  Synchronous and metachronous adenocarcinomas of the large intestine. , 2008, Hippokratia.

[9]  J. Patard,et al.  Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. , 2007, The Journal of urology.

[10]  Andrew J Vickers,et al.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. , 2006, The Lancet. Oncology.

[11]  P. Russo,et al.  Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Cheville,et al.  Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. , 2005, Journal of Urology.

[13]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[14]  J. Cheville,et al.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. , 2004, The Journal of urology.

[15]  P. Russo,et al.  Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  W. Marston Linehan,et al.  Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. , 2014, Urologic oncology.

[17]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.